Express News | Three-Year Results for Eylea Hd® (Aflibercept) Injection 8 Mg Demonstrate Continued Durable Vision Gains and Anatomic Improvements With Extended Dosing Intervals in Patients With Diabetic Macular Edema
Jefferies Adjusts Price Target on Regeneron Pharmaceuticals to $1,205 From $1,245
Here's What to Expect From Regeneron Pharmaceuticals' Next Earnings Report
Truist Financial Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $1,137
Regeneron Pharma Is Maintained at Buy by Truist Securities
Regeneron Pharmaceuticals Analyst Ratings
Express News | Regeneron Pharmaceuticals Inc : Truist Securities Cuts Target Price to $1137 From $1200
Jasper Gains 11% on Data for Briquilimab in Urticaria
After eight weeks of selling off, the hedge fund bought back US stocks, achieving the fastest speed since 2021.
The US stock market is currently experiencing active buying and market growth, but the market's high valuation is a concerning issue that may trigger future adjustments.
The bull market in US stocks will enter its third year. The three major stock index futures show mixed movements before the market opens. | Tonight's highlights
①The Nasdaq 100 index futures rose more than 0.4% in pre-market trading; ②Apple is set to launch a $2000 Vision headset as early as next year; ③Taiwan Semiconductor plans to establish more chip factories in Europe; ④GlaxoSmithKline's experimental drug for treating rhinitis has shown positive results.
"Weight-loss miracle drug" causing muscle loss, biotechnology companies like Regeneron Pharmaceuticals (REGN.US) are developing new treatments.
Wegovy and Zepbound, along with other GLP-1 class drugs, have significant effects on weight loss, but this weight loss largely reduces muscle mass.
Weight Loss Drugs Have One Big Issue; These Companies Want to Fix It
Morgan Stanley Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $1,235
Are the side effects of GLP-1 drugs too severe? Danish pharmaceutical company Zealand is advancing the "next generation of weight loss drugs".
①Although novo-nordisk a/s and eli lilly and co's drugs are very effective in weight loss, the side effects they bring should not be ignored, including significant muscle loss and increased suicidal thoughts; ②Danish pharmaceutical company Zealand stated that a weight loss drug they are currently developing has higher weight loss quality - less muscle loss and fewer side effects.
Here's How Much $100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth Today
What the Options Market Tells Us About Regeneron Pharmaceuticals
Regeneron (REGN) Loses -11.32% in 4 Weeks, Here's Why a Trend Reversal May Be Around the Corner
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Regeneron Gains 13.5% Year to Date: How to Play the Stock?
Pharmaceutical company warns: if muscle loss issue is not addressed, 'miracle weight-loss drugs' may do more harm than good.
①USA pharmaceutical company Regeneron stated that current GLP-1 weight loss drugs can lead to rapid muscle loss, and the company is developing a weight loss drug that can overcome this flaw; ② Regeneron warned that if the muscle loss issue is not resolved, GLP-1 weight loss drugs may do more harm than good.